Delivery Order SPE2DB20D1004-SPE2DB23FG3W3
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,460.70, is for the supply of Cephalexin 250 mg/5 ml suspension in 100 ml quantities. The contract has a July 12, 2024 completion date and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,725.49 firm fixed-price delivery order is for the supply of Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication. The contract has an ultimate completion date of September 27, 2023 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,300.51 firm fixed-price delivery order is for the supply of 4564427862 Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication. The contract has an ultimate completion date of April 30, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $13,309.59 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract provides for the supply of 4566614119 - Cephalexin 250 mg/5 ml suspension, 200 ml, a generic antibiotic medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,081.26, is a Delivery Order for the supply of Cephalexin 250 mg/5 ml suspension in 100 ml quantities. The contract has an ultimate completion date of May 9, 2023 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
- The U.S. Defense Logistics Agency (DLA) awarded a $14,943.32 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,563,045,324 units of Cephalexin 250 mg/5 ml suspension with a 100 ml volume. The contract, which has an ultimate completion date of December 11, 2023, was not set aside for any specific business designation. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,712.86 firm-fixed-price delivery order is for the supply of 4561247098 - Cephalexin 250 mg/5 ml suspension, 200 ml, with a period of performance through June 15, 2023. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,302.02 delivery order is for the supply of Cephalexin 250 mg/5 ml suspension in 100 ml containers. The contract has a firm fixed price and an ultimate completion date of January 12, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,780.23, is for the delivery of Cephalexin 250 mg/5 ml suspension in 100 ml containers. This is a firm fixed-price delivery order contract with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit organization and leading global pharmaceutical sourcing and distribution services company. The $10,230.71 fixed-price delivery order is for the supply of Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication, with a period of performance through March 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB23FG3W3Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,419.07 firm fixed-price delivery order covers the supply of Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication, with an ultimate completion date of August 16, 2023. The contract is not designated under a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 8/15/23 |